Life Sciences Collaborative
The Life Sciences Collaborative (LSC) is a select group of founders and investors that share a common vision for enhancing the success of emerging businesses in the biotechnology, medtech, and digital health sectors through peer-to-peer learning, connecting and building professional relationships.
The Collaborative has built thriving groups over the last ten years in the Princeton, NJ, Philadelphia/King of Prussia, PA, and most recently in Boston, MA, regions all of which are homes to leading life science innovation clusters.
One of the Collaborative’s great strengths is the opportunity for members to build connections across these key regions
Who we are
The Life Sciences Collaborative is a select group of industry veterans and executives from the pharmaceutical, biotechnology, and medical device sectors, and industry service providers who share a common vision of increasing the success of emerging life sciences businesses in the Mid-Atlantic Region.
LSC activities are built around small, informal, monthly breakfast educational and networking meetings. These sessions focus on topics around innovation and investment, including industry trends, practical issues related to growing and managing innovative businesses, and best practices.
The meetings also include presentations by emerging companies, providing them with opportunities to get expert feedback on their technologies and to expand their networks.
Mission Statement
The mission of the Life Sciences Collaborative is to promote connectivity among leaders in emerging life sciences businesses through networking, education, training, and mentorship with the goal of advancing professional development and business growth in the Mid-Atlantic Region.
LSC is a volunteer organization. It is neither sponsorship nor membership dues driven. If you are interested in participating in LSC’s monthly breakfast meetings, please contact us.
OUR MEMBERS
CEOs, Directors, Private Equity and Venture partners, Angel investors. Members may have successful track record leading public or private companies.
Mike Daley, Ph.D
OrthogenRX
Pam Layton
Chief Executive Officer at 4Immune Therapeutics
Peter Rock
LeviSense Medical
Prathamesh Prabhudesai
Co-Founder & CEO at SafeBVM
Rami Levin
Founder & CEO, The Outcomes Group
Raphael Nir, Ph.D
SBH Sciences
Rick Williams
Williams Advisory Partners
Robert Gottleib
RMG Associates, LLC
Ryan Udell
Partner
